Genky DrugStores Co., Ltd. (TYO:9267)
3,735.00
-70.00 (-1.84%)
Jul 15, 2026, 3:30 PM JST
Genky DrugStores Revenue
Genky DrugStores had revenue of 52.45B JPY in the quarter ending March 20, 2026, with 7.86% growth. This brings the company's revenue in the last twelve months to 215.11B, up 9.94% year-over-year. In the fiscal year ending June 20, 2025, Genky DrugStores had annual revenue of 200.79B with 8.62% growth.
Revenue (ttm)
215.11B
Revenue Growth
+9.94%
P/S Ratio
0.54
Revenue / Employee
116.85M
Employees
1,841
Market Cap
116.05B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 20, 2025 | 200.79B | 15.93B | 8.62% |
| Jun 20, 2024 | 184.86B | 15.80B | 9.35% |
| Jun 20, 2023 | 169.06B | 14.42B | 9.32% |
| Jun 20, 2022 | 154.64B | 12.26B | 8.61% |
| Jun 20, 2021 | 142.38B | 18.77B | 15.19% |
| Jun 20, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 20, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 20, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 20, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 20, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| KOSE Holdings | 329.46B |
| Cawachi | 284.49B |
| Earth | 182.31B |
| Pola Orbis Holdings | 169.80B |
| MTG Co., Ltd. | 118.64B |
| Pigeon | 111.65B |
| Noevir Holdings | 63.30B |
| Milbon | 54.10B |